[Cancer immunotherapy: new approaches].
Blay
J Y
JY
Unité Inserm 453, Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon et Unité d'oncologie médicale, hôpital édouard-Herriot, place d'Arsonval, 69003 Lyon.
Thomachot
M C
MC
Alberti
L
L
Bachelot
T
T
Voorzanger-Rousselot
N
N
Puisieux
I
I
Odin
L
L
Ménétrier-Caux
C
C
D019496:Cancer Vaccines / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive / Q000379:methods; D007167:Immunotherapy / Q000379:methods*; D007372:Interferons / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D019860:Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000637:transplantation*
D019496:Cancer Vaccines; D007376:Interleukin-2; D009363:Neoplasm Proteins; D007372:Interferons; D019860:Lymphocyte Specific Protein Tyrosine Kinase p56(lck)